When you start a medication like Dupixent (dupilumab), you expect relief from eczema or asthma, not the devastation of a cancer diagnosis. Yet growing medical evidence shows that some patients developed cutaneous T-cell lymphoma (CTCL) and other rare cancers soon after beginning Dupixent treatment….
By: Morris James LLP
                By: Morris James LLP
            